The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth
Authors:
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 29, 115856
Abstract
No abstract availableKeywords
Funding Information
- China Pharmaceutical University (CPU2018GF02)
- National Natural Science Foundation of China (81973182)
- National Natural Science Foundation of China (81673301)
This publication has 38 references indexed in Scilit:
- Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NFκB2 signaling that contributes to autoimmunityProceedings of the National Academy of Sciences, 2011
- Regulation and Function of NF-κB Transcription Factors in the Immune SystemAnnual Review of Immunology, 2009
- Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinonesBioorganic & Medicinal Chemistry Letters, 2007
- NF-κB and the immune responseOncogene, 2006
- Regulation of naive T cell function by the NF-κB2 pathwayNature Immunology, 2006
- IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesisNature, 2004
- NF-κB regulation in the immune systemNature Reviews Immunology, 2002
- A Small Molecule Ubiquitination Inhibitor Blocks NF-κB-dependent Cytokine Expression in Cells and RatsJournal of Biological Chemistry, 2002
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.Genes & Development, 1995